Doctor profile · Federal record
Dr. Raja Mehdi, MD
Hematology & Oncology Physician (CMS: Medical Oncology) · Medical Oncology Physician · Las Vegas, NV
- NPI 1366441743
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 29 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6827 W Tropicana Ave, 110
Las Vegas, NV 891034918
(702) 508-9128
fax (702) 302-4125 - Mailing address
-
Po Box 749495
Atlanta, GA 303749495
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- January 10, 2023
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Nevada #12720
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1366441743. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
119,239
Distinct HCPCS
10
Medicare allowed
$1,594,821
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9263 |
Injection, oxaliplatin, 0.5 mg | 25,500 | 15 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 22,230 | 43 | $2 | |
J9271 |
Injection, pembrolizumab, 1 mg | 20,200 | 23 | $54 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14,790 | 17 | $1 | |
J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 12,540 | 12 | $1 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,640 | 12 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,848 | 57 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,640 | 19 | $22 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 2,190 | 53 | $1 | |
J9190 |
Injection, fluorouracil, 500 mg | 997 | 20 | $2 |
In context: peer comparison
Among 14 peers in Las Vegas Hematology & Oncology Physician, average services per provider: 2,513. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$2,409
Transactions
82
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | 4 | $284.03 | |
| Astellas Pharma US INC | 6 | $227.00 | |
| Sobi, INC | 4 | $213.10 | |
| AstraZeneca Pharmaceuticals Lp | 10 | $208.97 | |
| Daiichi Sankyo INC. | 31 | $176.90 | |
| Abbott Laboratories | 1 | $174.54 | |
| Boston Scientific Corporation | 2 | $171.00 | |
| Tactile Systems Technology INC | 3 | $145.66 | |
| Genzyme Corporation | 2 | $130.16 | |
| Pfizer INC. | 5 | $119.62 | |
| Tempus Ai, INC | 4 | $105.26 | |
| Merck Sharp & Dohme LLC | 3 | $85.04 | |
| Celgene Corporation | 3 | $71.12 | |
| Dendreon Pharmaceuticals LLC | 2 | $67.13 | |
| Janssen Biotech, INC. | 2 | $65.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
946
Patients
484
Total drug cost
$1,272,018
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 192 | 88 | $4,783 |
| Prochlorperazine Maleate | Generic | 158 | 104 | $4,267 |
| Anastrozole | Generic | 126 | 52 | $2,383 |
| Ondansetron Odt (Ondansetron) | Brand | 109 | 94 | $4,824 |
| Tamoxifen Citrate | Generic | 52 | 19 | $1,774 |
| Gabapentin | Generic | 49 | 16 | $417 |
| Hydroxyurea | Generic | 41 | 14 | $587 |
| Dexamethasone | Generic | 33 | 23 | $817 |
| Ibrance (Palbociclib) | Brand | 31 | 0 | $502,615 |
| Ondansetron Hcl | Generic | 29 | 20 | $1,079 |
Frequently asked questions
What is Dr. Raja Mehdi's medical specialty?
Dr. Raja Mehdi practices Hematology & Oncology Physician in Las Vegas, NV.
Where does Dr. Raja Mehdi practice?
Dr. Raja Mehdi practices at 6827 W Tropicana Ave, Las Vegas, NV 891034918. Office phone: 7025089128.
What is Dr. Raja Mehdi's NPI?
Dr. Raja Mehdi's National Provider Identifier (NPI) is 1366441743, issued by NPPES.
Does Dr. Raja Mehdi accept Medicare assignment?
Yes. Dr. Raja Mehdi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Raja Mehdi commonly perform?
Top Medicare-reported procedures in 2023: Injection, oxaliplatin, 0.5 mg (HCPCS J9263); Injection, aprepitant, 1 mg (HCPCS J0185); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.